Genenta Science S.p.A.

$1.84

+$0.81 (78.64%)
Time to buy GNTA?
2 Days. Real Options Skills.

2 Days. Real Options Skills.

Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.

Save your seat

Trader's Perspective

GNTA ran from roughly $0.62 on May 20, 2026 to $1.80 now as traders chased its defense and aerospace pivot after the Sòphia High Tech deal and a fresh capital-raising setup into the June shareholder vote.

RANGE
Support: $1.50Current: $1.80 Target: $2.75
BEARISH SCENARIO

A failure to hold $1.50 could see a retrace toward $1.00 to $1.20. Any selling tied to Nasdaq bid-price pressure, dilution risk from the proposed capital authorization, or a weak read on the June 29, 2026 shareholder meeting would accelerate the downside.

BULLISH SCENARIO

If GNTA holds the $1.50 to $1.60 area on volume, a push back toward $2.25 to $2.75 is on the table. First resistance sits near $2.00, and any follow-through on the Sòphia HT closing or broader defense-sector momentum could keep dip buyers interested.

CATALYSTS:
Analysis generated: June 1, 2026 at 12:49 PM ET

Top Gainers

Analyst Ratings

N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0

Genenta Science S.p.A. Earnings

We don't currently have information about Genenta Science S.p.A.'s earnings.

The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders